Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 5551-5600 of 6050 result(s).
CYDY CytoDyn Inc
12/22/2019 9:54:01 AM
The ROI is irrespective of the need (2)
CYDY CytoDyn Inc
12/22/2019 9:27:10 AM
It seems medical science writers an (1)
CYDY CytoDyn Inc
12/22/2019 7:40:05 AM
Thanks for your reply. Do you think (1)
CYDY CytoDyn Inc
12/22/2019 5:44:04 AM
By the time we have approval and mT
CYDY CytoDyn Inc
12/21/2019 11:48:02 PM
NP and the BOD will have a legacy i (1)
CYDY CytoDyn Inc
12/21/2019 11:25:01 PM
Vyera would want more cash then we (1)
CYDY CytoDyn Inc
12/21/2019 11:14:28 PM
Hopefully a share swap so whomever (1)
CYDY CytoDyn Inc
12/21/2019 11:57:22 AM
What about we go alone for cancer i (3)
CYDY CytoDyn Inc
12/21/2019 6:19:03 AM
Participant satisfaction and qualit (4)
CYDY CytoDyn Inc
12/20/2019 8:17:52 PM
Leronlimab and non-HIV Indications (2)
CYDY CytoDyn Inc
12/20/2019 7:23:59 AM
NP mentioned reducing fibrosis in t (1)
CYDY CytoDyn Inc
12/19/2019 9:33:28 PM
Yes Indeed! UJOjTNuuEVw (1)
CYDY CytoDyn Inc
12/19/2019 8:05:02 PM
If you want to be a stock market an
CYDY CytoDyn Inc
12/19/2019 10:54:58 AM
Pestell will probably sue Cytodyn f (4)
CYDY CytoDyn Inc
12/19/2019 9:52:01 AM
Rising at the rate of 5% every 10 m
CYDY CytoDyn Inc
12/18/2019 9:25:41 AM
Vyera may also pay the Company addi (1)
CYDY CytoDyn Inc
12/18/2019 8:03:04 AM
Why would I sell? It's possible Vye (1)
CYDY CytoDyn Inc
12/18/2019 6:27:17 AM
You’re thinking about our partner
CYDY CytoDyn Inc
12/18/2019 3:12:24 AM
What I want to know - What's the pr (2)
CYDY CytoDyn Inc
12/18/2019 2:51:24 AM
Shkreli is a narcissistic idiot. ht
CYDY CytoDyn Inc
12/17/2019 4:28:44 PM
Shkreli's former company. That's wo (2)
CYDY CytoDyn Inc
12/17/2019 9:41:11 AM
Findore, Sarissa and Joshua Gold Re
CYDY CytoDyn Inc
12/17/2019 9:27:10 AM
Did Mr. Currah decide to pay us a v (2)
CYDY CytoDyn Inc
12/17/2019 8:27:44 AM
as should buyout
CYDY CytoDyn Inc
12/16/2019 9:02:39 AM
But we don't need them and I don't (1)
CYDY CytoDyn Inc
12/16/2019 8:59:46 AM
Patents - I think I've finally foun (5)
CYDY CytoDyn Inc
12/15/2019 9:02:16 AM
What’s somewhat worrying though i (3)
CYDY CytoDyn Inc
12/15/2019 4:23:18 AM
Is NP in your point of view not wil (1)
CYDY CytoDyn Inc
12/15/2019 3:33:37 AM
I have to state that you were rarel (3)
CYDY CytoDyn Inc
12/15/2019 1:54:52 AM
I'm going to take actions. If you w (4)
CYDY CytoDyn Inc
12/14/2019 1:38:47 PM
What is most important is the lower
CYDY CytoDyn Inc
12/14/2019 11:48:47 AM
Which just goes to show the irratio
CYDY CytoDyn Inc
12/14/2019 5:13:07 AM
So what do you expect in regards to
CYDY CytoDyn Inc
12/14/2019 4:45:16 AM
It would not be insider trading unl
CYDY CytoDyn Inc
12/14/2019 4:19:48 AM
A Tale of Two Companies: Matinas Bi (2)
CYDY CytoDyn Inc
12/13/2019 9:06:35 PM
you would conclude he is the wrong (1)
CYDY CytoDyn Inc
12/13/2019 6:46:16 AM
She was embarrassed by it or at lea (2)
CYDY CytoDyn Inc
12/12/2019 9:11:58 PM
Due to leronlimab allowing normal i
CYDY CytoDyn Inc
12/12/2019 12:04:50 PM
BTW HIV also mutates and eventually (1)
CYDY CytoDyn Inc
12/12/2019 10:07:49 AM
There are two things to look at. So (1)
CYDY CytoDyn Inc
12/12/2019 9:23:33 AM
With no drug for NASH that has a de
CYDY CytoDyn Inc
12/12/2019 7:57:13 AM
For biologics there is 12 years exc (1)
CYDY CytoDyn Inc
12/11/2019 1:23:54 PM
That is not price fixing. Price fix (2)
CYDY CytoDyn Inc
12/11/2019 12:25:31 PM
We don't know yet if there will be (1)
CYDY CytoDyn Inc
12/11/2019 11:48:22 AM
In the best of all possible worlds, (1)
CYDY CytoDyn Inc
12/11/2019 11:41:27 AM
The answer is clear. Cancer treatme (2)
CYDY CytoDyn Inc
12/11/2019 10:47:15 AM
Friday he should put out a clear, c (4)
CYDY CytoDyn Inc
12/10/2019 10:53:45 AM
It looks like Pestell is dumping sh
CYDY CytoDyn Inc
12/10/2019 9:40:36 AM
Proinflamatory cytokines secreted b (4)
CYDY CytoDyn Inc
12/10/2019 7:43:32 AM
No one knows Why would you infer th (1)
Go to page:
  • << First
  • < Previous
  • 111
  • 112
  • Next >

Recent Articles

  • Continuing the Vision: Legacy of Charlie Kirk Lives On
  • Lantheus Holdings Faces Securities Fraud Class Action Opportunity
  • Investors Can Take Legal Action in LifeMD Securities Case Soon
  • Investors Urged to Act: Nutex Health Class Action Deadline Nears
  • Clearing the Path: How US Regulations Could Propel Bitcoin
  • Embracing Diversity: Celebrating the Power of Hispanic Communities
  • Essential Steps to Consider Before Rolling Over Your 401(k)
  • Exploring the Transformative Power of Equine Therapy in Senior Care
  • Important Deadline Approaching for Lockheed Martin Investors
  • Essential Seasonal Guidance for Lakefront Property Buyers
  • Global AI Race: Buck Sexton Highlights America's Future Stakes
  • Tech Breakthroughs and Market Movements: Insights and Highlights
  • Amaury Pierron Achieves Victory at 2025 UCI Downhill Cup
  • Taliban Stands Firm Against Trump's Demands Over Bagram Base
  • Investing Insights: Stocks to Keep on Your Radar
  • Investigation of Class Action Claims for Charter Communications
  • Investigation Announced for Fiserv Investors Over Potential Losses
  • Lantheus Faces Legal Scrutiny: Investor Options Explained
  • Apple's iPhone 17 Launch, Meta Glasses, And AI Partnerships
  • Max Stock Limited Reveals Increased Shareholdings by Director
  • BYOMA's Innovative Blemish Solutions to Empower Skincare Users
  • Unlocking Skyward Innovation: Lockheed Martin's Vectis System
  • Lead Investors in Savara Inc. Pivotal Lawsuit for SEC Violations
  • Nutex Health Faces Serious Legal Challenges: Updates Inside
  • Investigation into Quantum Corporation Investor Claims Alert
  • Tesla Faces Model Y Investigation Amid Growing Industry Dynamics
  • Faruqi & Faruqi Investigates Investor Claims Against SelectQuote
  • Investigating Claims Against Semler Scientific: What You Need to Know
  • Unicycive Therapeutics: Legal Claims Investigation Focus
  • Legal Team Seeks Investors Impacted by Tronox Holdings' Decline
  • Investigation into Replimune Group, Inc: Shareholder Claims
  • Investigation into Flywire Corporation Sparks Investor Interest
  • Investigation Launched for LifeMD Investors Over Claims
  • Investigation Insights into Lockheed Martin’s Potential Shareholder Claims
  • Investigation Launched for PubMatic Investors Amid Claims
  • Understanding the Recently Underperforming Large-Cap Stocks
  • Exploring Digital Innovations at the World Internet Conference
  • Faruqi & Faruqi Investigates Savara's Securities Claims Now
  • Investigation by Faruqi & Faruqi on RxSight Securities Claims
  • Bitcoin Investors Explore XRP Tundra Presale Opportunity
  • Latest Trends in Cryptocurrency: O'Leary's Views and More
  • Important Updates for RxSight, Inc. Investors Facing Losses
  • Last Week's Large-Cap Stock Winners: Insights and Trends
  • Important Class Action for Replimune Group Investors Revealed
  • Honoring Charlie Kirk: A Legacy of Faith and Freedom
  • LiTime's Innovative Battery Solutions Shine in European RV Market
  • Mike Pence Takes on New Role in Academia at George Mason
  • Warren Buffett Shares Key Insights from Charlie Munger on Investing
  • Trump Uses 'Golden Share' Power to Keep US Steel Plant Open
  • Pujiang Innovation Forum: Bridging Global Tech Communities
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site